Source:http://linkedlifedata.com/resource/pubmed/id/21029268
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2011-3-11
|
pubmed:abstractText |
This review aims to examine economic evaluations of varenicline, to compare the reported cost-effectiveness of varenicline with that of treatments for major smoking-related diseases and to evaluate the findings for decision making.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1365-2753
|
pubmed:author | |
pubmed:copyrightInfo |
© 2010 Blackwell Publishing Ltd.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
288-97
|
pubmed:meshHeading | |
pubmed:year |
2011
|
pubmed:articleTitle |
A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities.
|
pubmed:affiliation |
Senior Health Technology and Clinical Evidence Reviewer, Head of European Operations, RTI Health Solutions, Williams House, Manchester Science Park, Manchester, UK. ezimovetz@rti.org
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Review,
Research Support, Non-U.S. Gov't
|